Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS
· Delayed Price · Currency is USD
2.360
0.00 (0.00%)
Jun 18, 2025, 4:00 PM EDT
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $7.37 million as of June 23, 2025. Its market cap has increased by 42.53% in one year.
Market Cap
7.37M
Enterprise Value
3.17M
Revenue
519.87K
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.36
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 7.37M, a decrease of -72.75%. That is a compound annual growth rate of -40.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 7.37M | 99.91% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.62B |
| Veradigm | 755.74M |
| Elite Pharmaceuticals | 715.74M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 637.25M |
| American Oncology Network | 414.48M |
| Glass House Brands | 408.56M |
| CytoDyn | 398.27M |